Program Impact At A Glance
Accelerating Biomedical Innovation Across Texas
Program Impact At A Glance
100+
Strategic Advisors Involved
26
73
Texas Institutions Engaged
Technology Feedback Forums
19
Commercialization Plans
$2.7
22
Million in Follow On Funding
Interns assigned to Projects
What is GCC REACH?
The Gulf Coast Consortium Research Evaluation and Commercialization Hub (GCC-REACH) is an NIH funded multi-institutional resource wherein nascent academic entrepreneurs work closely with successful life science experts and experienced biotech executives to develop strategic milestones to rapidly validate the commercial value of their discoveries. Entrepreneurs who balance full-time clinical, teaching, and laboratory duties will be paired with Entrepreneurs in Residence and expert teams who provide mentorship and assistance in completing, market analysis, business plans, and technology development strategies. The GCC-REACH assists entrepreneurs in strategic planning for management and operations and provides vetted resources and support to achieve value-added commercialization inflection points.
Commercialization Pipeline
TFF
Project Summaries
Cohort 1
Oral patch, Nanoparticles, Cancer therapy
Cohort 2
CAR-T, Brain injury therapy, Breast reconstruction
Cohort 3
eRNA therapeutics, Viral detection, Breast cancer therapy
Cohort 4
eRNA therapeutics, Viral detection, Breast cancer therapy
Cohort 5
eRNA therapeutics, Viral detection, Breast cancer therapy